Florida Center for Allergy and Asthma Care

What Florida Center for Allergy and Asthma Care does

Florida Center for Allergy and Asthma Care is a physician-owned, private medical practice founded in 1974 and headquartered in Fort Lauderdale, Florida. The practice specializes in the diagnosis and treatment of allergic, asthmatic, and immunologic conditions in both adults and children, and operates 19 clinic locations spanning the South Florida tri-county area of Miami-Dade, Broward, and Palm Beach Counties. Services span diagnostic testing (skin testing, patch testing, food allergy diagnosis) and a comprehensive treatment menu including subcutaneous immunotherapy (allergy shots), sublingual immunotherapy (allergy drops), oral immunotherapy, biologic injections such as Xolair/omalizumab, and management of asthma, eczema, and contact dermatitis. In 2024 the practice launched a dedicated Food Allergy Center offering three advanced desensitization modalities (SLIT, OIT with Palforzia for pediatric peanut allergy, and Xolair), positioning the practice in a higher-acuity segment of the regional market.

The business model is a fee-for-service, insurance-billed clinical practice. Revenue is generated from patient consultations, in-office procedures, allergy testing, and recurring immunotherapy/biologic administration visits, with most major commercial insurance plans accepted. Patient acquisition is driven by physician referrals, self-referrals, and direct appointment requests via phone, online form, or walk-in, supported by same-day urgent appointment availability, telemedicine for follow-ups, and bilingual English/Spanish service delivery. The practice maintains a research center for clinical trials and engages in community advocacy (Teal Pumpkin Project with AAFA and FARE) to support patient acquisition and brand visibility in food allergy.

The practice is led by President Dr. Jaime Landman (joined 1994) and Vice President Dr. Zevy Landman (joined 1997), both board-certified in allergy/immunology, providing leadership stability of nearly three decades. There is no evidence of external investment, private equity ownership, or parent company control; ownership and management appear to remain physician-led. Headcount is reported in the 51-100 range, consistent with a multi-site specialty group of this scale.

Name

Florida Center for Allergy and Asthma Care

Legal name

Florida Center For Allergy & Asthma Care

Website

https://florida-allergy.com

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

51–100 employees

Short description

Florida Center for Allergy and Asthma Care is a physician-owned allergy, asthma, and immunology practice founded in 1974, operating 19 clinic locations across South Florida's Miami-Dade, Broward, and Palm Beach counties and serving adult and pediatric patients with diagnostic testing, immunotherapy, and biologic treatments including a 2024 Food Allergy Center.

Ownership category

akta.pro rank

Product category

Allergy and Immunology Medical Services

NAICS

Ambulatory Health Care Services (621), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Food Allergy Evaluation & Management (HLAKAAAD), Asthma & Airway Disease Specialty Care (HLAKAAAC), Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL), Pediatric Allergy & Immunology (HLAKAAAB)

Keywords

• Allergy and asthma care
• Immunotherapy treatments
• Food allergy desensitization
• Allergy testing services
• Biologic injection therapy

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices20 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Clinical Services (Consultations, Testing, Treatments): Revenue generated from patient consultations, allergy testing, immunotherapy injections, and in-office procedures. Services are primarily billed through accepted insurance plans including major commercial insurers.
2. Xolair (omalizumab) Treatment: Biologic medication injection administered in-office every 2-4 weeks. Must be approved through insurance. Revenue from medication administration and office visits.
3. SLIT (Sublingual Immunotherapy) for Food Allergies: SLIT for food allergy not currently FDA-approved. Treatment available through combination of upfront payment for drops and consultations that can be billed through insurance.
4. Oral Immunotherapy (OIT): Treatment for peanut allergy (FDA-approved Palforzia for ages 4-17) and off-label OIT for tree nuts, milk, egg. Revenue from initial dosing visits, monthly updosing visits, and ongoing maintenance consultations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Florida Center for Allergy and Asthma Care provides diagnostic testing and treatment for allergies, asthma, and immune system disorders at 19 clinic locations across South Florida. Services include skin and patch allergy testing, subcutaneous immunotherapy (allergy shots), sublingual immunotherapy (allergy drops), asthma management, and treatment of eczema and contact dermatitis, with a recently launched Food Allergy Center offering SLIT for food allergies, oral immunotherapy (OIT), and Xolair (omalizumab) biologic injections.

Product overview

Florida Center For Allergy & Asthma Care is a healthcare provider offering a comprehensive suite of allergy, asthma, and immunology services through 19 locations in South Florida. The core offering includes diagnostic testing (allergy testing, patch testing, food allergy diagnosis) and treatment services (immunotherapy/allergy shots, sublingual immunotherapy/allergy drops, asthma management, eczema treatment). The company recently launched a dedicated Food Allergy Center offering three advanced treatment options: SLIT (Sublingual Immunotherapy) for food allergies, Oral Immunotherapy (OIT), and Xolair (omalizumab) injections for IgE-mediated food allergies.

Differentiator

Problem solved

Functional benefit

Products and services

• Allergy Testing Comprehensive diagnostic allergy testing to identify specific allergens triggering patient symptoms in adults and children.
• Immunotherapy (Allergy Shots) Subcutaneous immunotherapy treatment using allergy shots administered in clinic to desensitize patients to specific environmental allergens over time.
• Sublingual Immunotherapy (Allergy Drops) At-home allergy drop treatment placed under the tongue daily to build tolerance to environmental allergens, used for patients from infants to adults.
• Asthma Management Comprehensive asthma care including diagnosis, treatment planning, and ongoing management of asthma symptoms and triggers.
• Eczema (Contact Dermatitis) Treatment Clinical treatment for eczema and contact dermatitis skin conditions caused by allergic reactions.
• Patch Testing Diagnostic skin patch testing to identify substances causing contact dermatitis and skin allergic reactions.
• Food Allergy Center Dedicated center offering diagnosis and advanced treatment for IgE-mediated food allergies, including SLIT for food allergens, OIT desensitization, and Xolair biologic injections, for adults and pediatric patients.

Quantifiable outcome

• Xolair reduces risk of anaphylaxis from accidental food allergen exposure by increasing threshold of reactivity
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered moderate.

• AAFA (Asthma and Allergy Foundation of America)moderateStrategic or Co-development PartnerCollaborative partnership supporting the Teal Pumpkin Project initiative to make Halloween safe and inclusive for children with food allergies. AAFA leads the initiative alongside FARE to promote food allergy awareness.
• FARE (Food Allergy Research & Education)moderateStrategic or Co-development PartnerPartnership supporting the Teal Pumpkin Project initiative. FARE is a leading organization dedicated to food allergy research, education, and advocacy, working to make Halloween safer for food allergy patients.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• ENT and Allergy Associates (ENTAA): Large multi-site ENT and allergy practice across the New York tri-state area with board-certified allergists offering testing, immunotherapy, and food allergy treatments; comparable in scale, multi-site specialty model, and allergy service mix.
• Atlanta Allergy & Asthma: Large regional allergy and immunology practice group serving metro Atlanta with multiple locations offering allergy testing, immunotherapy, asthma management, and food allergy services; closely comparable in service mix and multi-site specialty model.
• Allergy & Asthma Associates of DuPage: Established multi-physician allergy and immunology group serving the Chicago suburbs; comparable as a long-tenured, physician-led regional allergy practice offering testing, immunotherapy, and asthma management.
• NY Allergy and Sinus Centers: Multi-location allergy, asthma, and sinus practice serving the New York metro area with diagnostic and treatment services; comparable as a metro-focused specialist offering immunotherapy and biologic treatments via board-certified allergists.
• Aspire Allergy & Sinus: Multi-location allergy, asthma, and sinus specialty practice operating across Texas and the Southwest; comparable in offering a full menu of allergy drops, shots, biologic therapies, and food allergy desensitization at clinic scale.

Broad incumbents

• Cleveland Clinic Allergy & Immunology: Major academic health system with a dedicated allergy and immunology department; comparable as a large-scale provider of allergy diagnostics, immunotherapy, and biologic treatments including food allergy desensitization.
• AllerVie Health: National platform operating a network of allergy and asthma practices across multiple states; comparable to FCAAC as a multi-site allergy specialist delivering diagnostics, immunotherapy, and biologic treatments through board-certified allergists.
• Family Allergy & Asthma (now US Allergy & Asthma): Multi-state allergy and asthma practice platform headquartered in Kentucky operating numerous clinics; comparable as a scaled regional-to-national specialty practice delivering skin testing, immunotherapy, and biologic services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/floridaallergy
• Xx.com/florida_allergy
• Facebookfacebook.com/FloridaAllergy

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Florida Center for Allergy and Asthma Care